367 related articles for article (PubMed ID: 36060266)
1. A cuproptosis-related lncRNAs signature for prognosis, chemotherapy, and immune checkpoint blockade therapy of low-grade glioma.
Yan X; Wang N; Dong J; Wang F; Zhang J; Hu X; Zhao H; Gao X; Liu Z; Li Y; Hu S
Front Mol Biosci; 2022; 9():966843. PubMed ID: 36060266
[TBL] [Abstract][Full Text] [Related]
2. Machine learning identification of cuproptosis and necroptosis-associated molecular subtypes to aid in prognosis assessment and immunotherapy response prediction in low-grade glioma.
Miao Y; Liu J; Liu X; Yuan Q; Li H; Zhang Y; Zhan Y; Feng X
Front Genet; 2022; 13():951239. PubMed ID: 36186436
[TBL] [Abstract][Full Text] [Related]
3. A novel cuproptosis-related LncRNA signature: Prognostic and therapeutic value for low grade glioma.
Wen J; Zhao W; Shu X
Front Oncol; 2022; 12():1087762. PubMed ID: 36776374
[TBL] [Abstract][Full Text] [Related]
4. Prognosis and immune response of a cuproptosis-related lncRNA signature in low grade glioma.
Xu Y; Wang C; Li S; Zhou H; Feng Y
Front Genet; 2022; 13():975419. PubMed ID: 36338998
[TBL] [Abstract][Full Text] [Related]
5. Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas.
Bao JH; Lu WC; Duan H; Ye YQ; Li JB; Liao WT; Li YC; Sun YP
Front Immunol; 2022; 13():933973. PubMed ID: 36045691
[TBL] [Abstract][Full Text] [Related]
6. A novel signature of cuproptosis-related lncRNAs predicts prognosis in glioma: Evidence from bioinformatic analysis and experiments.
Chen D; Xu Y; Gao X; Zhu X; Liu X; Yan D
Front Pharmacol; 2023; 14():1158723. PubMed ID: 37101543
[No Abstract] [Full Text] [Related]
7. Comprehensive analysis of the prognostic signature and tumor microenvironment infiltration characteristics of cuproptosis-related lncRNAs for patients with colon adenocarcinoma.
Cui G; Liu J; Wang C; Gu R; Wang M; Sun Z; Wei F
Front Oncol; 2022; 12():1007918. PubMed ID: 36212459
[TBL] [Abstract][Full Text] [Related]
8. Novel Cuproptosis-Related Gene Signature for Precise Identification of High-Risk Populations in Low-Grade Gliomas.
Chen P; Han H; Wang X; Wang B; Wang Z
Mediators Inflamm; 2023; 2023():6232620. PubMed ID: 36814682
[TBL] [Abstract][Full Text] [Related]
9. Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma.
Xu M; Mu J; Wang J; Zhou Q; Wang J
Front Oncol; 2022; 12():961213. PubMed ID: 35965536
[TBL] [Abstract][Full Text] [Related]
10. Identification of cuproptosis-related subtypes and the development of a prognostic model in glioma.
Wu Z; Li W; Zhu H; Li X; Zhou Y; Chen Q; Huang H; Zhang W; Jiang X; Ren C
Front Genet; 2023; 14():1124439. PubMed ID: 36936439
[No Abstract] [Full Text] [Related]
11. A Novel lncRNA Panel Related to Ferroptosis, Tumor Progression, and Microenvironment is a Robust Prognostic Indicator for Glioma Patients.
He Y; Ye Y; Tian W; Qiu H
Front Cell Dev Biol; 2021; 9():788451. PubMed ID: 34950662
[No Abstract] [Full Text] [Related]
12. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma.
Zhang M; Wang X; Chen X; Zhang Q; Hong J
Front Genet; 2020; 11():363. PubMed ID: 32351547
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of cuproptosis-related lncRNAs to predict prognosis and immune infiltration characteristics in colorectal cancer.
Zhu Z; Zhao Q; Li S; Weng J; Guo T; Zhu C; Xu Y
Front Genet; 2022; 13():984743. PubMed ID: 36467996
[No Abstract] [Full Text] [Related]
14. A cuproptosis-based prognostic model for predicting survival in low-grade glioma.
Zhao Z; Ma Y; Liu Y; Chen Z; Zheng J
Aging (Albany NY); 2024 May; 16(10):8697-8716. PubMed ID: 38738989
[TBL] [Abstract][Full Text] [Related]
15. A novel cuproptosis-related lncRNA nomogram to improve the prognosis prediction of gastric cancer.
Feng A; He L; Chen T; Xu M
Front Oncol; 2022; 12():957966. PubMed ID: 36106123
[TBL] [Abstract][Full Text] [Related]
16. Identification of cuproptosis-related lncRNAs for prognosis and immunotherapy in glioma.
Wang L; Li Y; Wang Y; Li J; Sun Y; Chen J; Wang Z
J Cell Mol Med; 2022 Dec; 26(23):5820-5831. PubMed ID: 36317420
[TBL] [Abstract][Full Text] [Related]
17. Establishment and validation of a cuproptosis-related lncRNA signature that predicts prognosis and potential targeted therapy in hepatocellular carcinoma.
Guo DF; Fan LW; Zeng HH; Huang CB; Wu XH
Biotechnol Genet Eng Rev; 2023 Mar; ():1-26. PubMed ID: 36951200
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of a novel cuproptosis-related lncRNA signature associated with prognosis and tumor matrix features to predict immunotherapy in soft tissue carcinoma.
Liu B; Pang K; Feng C; Liu Z; Li C; Zhang H; Liu P; Li Z; He S; Tu C
Front Genet; 2022; 13():1063057. PubMed ID: 36568384
[No Abstract] [Full Text] [Related]
19. Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma.
Xu S; Liu D; Chang T; Wen X; Ma S; Sun G; Wang L; Chen S; Xu Y; Zhang H
Front Genet; 2022; 13():938259. PubMed ID: 35910212
[No Abstract] [Full Text] [Related]
20. A Hypoxia-Related Long Non-Coding RNAs Signature Associated With Prognosis in Lower-Grade Glioma.
Feng Q; Qian C; Fan S
Front Oncol; 2021; 11():771512. PubMed ID: 34869006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]